“Today, the U.S. Food and Drug Administration expanded the approval of the COVID-19 treatment Veklury (remdesivir) to include pediatric patients 28 days of age and older weighing at least 3 kilograms (about 7 pounds) with positive results of direct SARS-CoV-2 viral testing,” the FDA said in a press release. The approval includes children who are: … Continue reading FDA Approves Remdesivir for Young Children